Use the Search Fields to Find Information
Page 37 of 382
The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
Abstract Cannabinoids have long been used for their psychotropic and possible medical properties of symptom relief. In the past few years, a vast literature
August 24, 2023
The Impact of Cannabidiol on Psychiatric and Medical Conditions
Abstract Cannabidiol (CBD) is a substance chemically derived from Cannabis sativa and discussed to be non-psychoactive. According to the FDA, marijuana is classified as a
July 1, 2024
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Abstract Background: Accumulating evidence suggests that the non-intoxicating cannabinoid compound cannabidiol (CBD) may have antipsychotic and anxiolytic properties, and thus may be a promising new
April 1, 2024
The highs and the lows: Recreational marijuana laws and mental health treatment
Abstract Recreational marijuana laws (RMLs) continue to grow in popularity, but the effects on mental health treatment are unclear. This paper uses an event-study
August 23, 2023
The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use
Abstract BACKGROUND: Evidence on the cardiovascular health effects of cannabis use is limited. We designed a prospective cohort study of older Veterans (66 to 68
February 20, 2024
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment
Abstract The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients seeking certification for MMJ use
November 15, 2023
The Genetic Structure of Marijuana and Hemp
Abstract Despite its cultivation as a source of food, fibre and medicine, and its global status as the most used illicit drug, the genus
September 1, 2022
The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
Background: Cannabinoids represent unique compounds for treating tumors, including astrocytomas. Whether CB1 and CB2 receptors mediate this therapeutic effect is unclear. Principal Findings: We generated
September 19, 2019
The Exploration of Cannabis and Cannabinoid Therapies for Migraine
Please use this link to access this publication. Abstract Purpose of review: There is increasing interest in the use of cannabis and cannabinoid therapies (CCT) by
September 5, 2024
The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review
Abstract Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The treatment gap in ASD has led to growing interest in alternative therapies,
December 17, 2024
Page 37 of 382